{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:26:01Z","timestamp":1792697161209,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute promyelocytic leukemia (APL) is associated with high early mortality, primarily due to hemorrhagic complications. Although treatment with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has dramatically improved outcomes, ATRA may induce severe adverse effects such as pseudotumor cerebri syndrome (PTCS). We report a 19-year-old female with high-risk APL who developed recurrent PTCS during induction and consolidation therapy with ATRA. Treatment with acetazolamide and reintroduction of a lower dosages proved insufficient, and repeated lumbar punctures were contraindicated due to significant procedural anxiety and patient distress. A lumboperitoneal (LP) shunt was placed, keeping intracranial pressure stable and enabling uninterrupted ATRA administration and successful completion of consolidation therapy. To our knowledge, this is the first documented use of an LP shunt to manage refractory PTCS in an APL patient. The case highlights cerebrospinal fluid diversion as a potential strategy to sustain life-saving ATRA therapy in patients with recurrent PTCS unresponsive to conservative measures.<\/jats:p>","DOI":"10.1007\/s00277-026-07078-x","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:45:53Z","timestamp":1779864353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of pseudotumor cerebri syndrome in acute promyelocytic leukemia: use of a lumboperitoneal shunt to facilitate continued ATRA therapy - a case report"],"prefix":"10.1007","volume":"105","author":[{"given":"Sara G.","family":"Creemers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens M. F.","family":"Dirven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Wlazlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"4","key":"7078_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.V41.4.489.489","volume":"41","author":"J Bernard","year":"1973","unstructured":"Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon MF (1973) Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood 41(4):489\u2013496 doi:S0006-4971(20)80093-7 [pii]","journal-title":"Blood"},{"key":"7078_CR2","doi-asserted-by":"publisher","unstructured":"Breccia M, Lo Coco F (2014) Thrombo-hemorrhagic deaths in acute promyelocytic leukemia. Thromb Res 133 Suppl 2S112\u2013116. https:\/\/doi.org\/10.1016\/S0049-3848(14)50019-9. [pii]","DOI":"10.1016\/S0049-3848(14)50019-9"},{"issue":"6","key":"7078_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1182\/blood.V57.6.1000.1000","volume":"57","author":"TR Breitman","year":"1981","unstructured":"Breitman TR, Collins SJ, Keene BR (1981) Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57(6):1000\u20131004 doi:S0006-4971(20)63266-9 [pii]","journal-title":"Blood"},{"issue":"3","key":"7078_CR4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","volume":"88","author":"GQ Chen","year":"1996","unstructured":"Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, Shen ZX, Sun GL, Ma J, Zhang P, Zhang TD, Gazin C, Naoe T, Chen SJ, Wang ZY, Chen Z (1996) In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins. Blood 88(3):1052\u20131061 doi:S0006-4971(20)62533-2 [pii]","journal-title":"Blood"},{"key":"7078_CR5","doi-asserted-by":"publisher","unstructured":"Tallman MS, Altman JK (2008) Curative strategies in acute promyelocytic leukemia. Hematol Am Soc Hematol Educ Program 391\u2013399. https:\/\/doi.org\/10.1182\/asheducation-2008.1.391. [pii]","DOI":"10.1182\/asheducation-2008.1.391"},{"issue":"4","key":"7078_CR6","first-page":"1192","volume":"94","author":"P Fenaux","year":"1999","unstructured":"Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Eur APL Group Blood 94(4):1192\u20131200 doi:S0006-4971(20)67338-4 [pii]","journal-title":"Eur APL Group Blood"},{"issue":"15","key":"7078_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","volume":"337","author":"MS Tallman","year":"1997","unstructured":"Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH (1997) All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 337(15):1021\u20131028. https:\/\/doi.org\/10.1056\/NEJM199710093371501","journal-title":"N Engl J Med"},{"issue":"2","key":"7078_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"ME Huang","year":"1988","unstructured":"Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72(2):567\u2013572 doi:S0006-4971(20)81033-7 [pii]","journal-title":"Blood"},{"issue":"9","key":"7078_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1182\/blood.V76.9.1704.1704","volume":"76","author":"S Castaigne","year":"1990","unstructured":"Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76(9):1704\u20131709 doi:S0006-4971(20)83086-9 [pii]","journal-title":"Blood"},{"key":"7078_CR10","doi-asserted-by":"publisher","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lubbert M, Hanel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Dohner K, Sauer M, Ganser A, Amadori S, Mandelli F, Dohner H, Ehninger G, Schlenk RF, Platzbecker U, Gruppo Italiano Malattie Ematologiche dA, German-Austrian Acute Myeloid Leukemia Study G, Study Alliance L (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369 (2):111-121. https:\/\/doi.org\/10.1056\/NEJMoa1300874","DOI":"10.1056\/NEJMoa1300874"},{"key":"7078_CR11","doi-asserted-by":"publisher","unstructured":"Platzbecker U, Ades L, Montesinos P, Ammatuna E, Fenaux P, Baldus C, Bernardi M, Berthon C, Bocchia M, Bonmati C, Borlenghi E, Bornhauser M, Carp D, Chantepie S, Crea E, Divona M, Dohner H, Ehninger G, Esteve Reyner J, Frayfer J, Garrido Diaz A, Gil C, Guarnera L, Hamm AF, Heiblig M, Heidenreich D, Kramer AJ, Ledoux MP, Lunghi M, Mancini V, Metzeler K, Miggiano MC, Muller-Tidow C, Peterlin P, Piciocchi A, Rieger K, Rollig C, Rossi G, Sanz MA, Serve H, Sohne M, Spiekermann K, Tavernier-Tardy E, Thiede C, Vives Polo S, Vogel W, Zappasodi P, Ziller-Walter P, Voso MT, Sal A-CA-SOPH, groups Gs (2025) Arsenic trioxide and all-trans retinoic acid combination therapy for the treatment of high-risk acute promyelocytic leukemia: results from the APOLLO trial. J Clin Oncol 43 (29):3160-3169. https:\/\/doi.org\/10.1200\/JCO-25-00535","DOI":"10.1200\/JCO-25-00535"},{"issue":"3","key":"7078_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.clml.2015.11.018","volume":"16","author":"CC Coombs","year":"2016","unstructured":"Coombs CC, DeAngelis LM, Feusner JH, Rowe JM, Tallman MS (2016) Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria. Clin Lymphoma Myeloma Leuk 16(3):146\u2013151 S2152-2650(15)01399-3 [pii]","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"7078_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4103\/0976-3147.133595","volume":"5","author":"TM Anoop","year":"2014","unstructured":"Anoop TM, Jain N, Nair SG, Narayanan G (2014) All-trans-retinoic acid-induced pseudotumor cerebri in acute promyelocytic leukemia. J Neurosci Rural Pract 5(3):273\u2013275. https:\/\/doi.org\/10.4103\/0976-3147.133595. [pii]","journal-title":"J Neurosci Rural Pract"},{"issue":"13","key":"7078_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159\u20131165. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a55f17. [pii]","journal-title":"Neurology"},{"issue":"6","key":"7078_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1055\/s-0039-1698744","volume":"39","author":"SR Ahmad","year":"2019","unstructured":"Ahmad SR, Moss HE (2019) Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension. Semin Neurol 39(6):682\u2013691. https:\/\/doi.org\/10.1055\/s-0039-1698744","journal-title":"Semin Neurol"},{"issue":"4","key":"7078_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1227\/neu.0000000000002086","volume":"91","author":"M Salih","year":"2022","unstructured":"Salih M, Enriquez-Marulanda A, Khorasanizadeh M, Moore J, Prabhu VC, Ogilvy CS (2022) Cerebrospinal Fluid Shunting for Idiopathic Intracranial Hypertension: A Systematic Review, Meta-Analysis, and Implications for a Modern Management Protocol. Neurosurgery 91(4):529\u2013540. https:\/\/doi.org\/10.1227\/neu.000000000000208600006123-202210000-00003 [pii]","journal-title":"Neurosurgery"},{"issue":"2","key":"7078_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239\u2013245. https:\/\/doi.org\/10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"7078_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00043426-200305000-00010","volume":"25","author":"KL Vanier","year":"2003","unstructured":"Vanier KL, Mattiussi AJ, Johnston DL (2003) Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia. J Pediatr Hematol Oncol 25(5):403\u2013404. https:\/\/doi.org\/10.1097\/00043426-200305000-00010","journal-title":"J Pediatr Hematol Oncol"},{"key":"7078_CR19","doi-asserted-by":"publisher","unstructured":"Holmes D, Vishnu P, Dorer RK, Aboulafia DM (2012) All-trans retinoic acid-induced pseudotumor cerebri during induction therapy for acute promyelocytic leukemia: a case report and literature review. Case Rep Oncol Med 2012(313057). https:\/\/doi.org\/10.1155\/2012\/313057","DOI":"10.1155\/2012\/313057"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07078-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:20:15Z","timestamp":1786785615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07078-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":19,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7078"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07078-x","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication has been obtained from the patient.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"344"}}